Diseases, Conditions, Syndromes

Thalidomide induces complete response in cutaneous lupus

(HealthDay) -- Low-dose thalidomide successfully induces complete response in a majority of patients with refractory cutaneous lupus erythematosus (CLE), according to research published in the March issue of the British Journal ...

Oncology & Cancer

Protein family key to aging, cancer

The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health (NIH).

Oncology & Cancer

Chemotherapy is as effective before breast cancer surgery as after

Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, ...

page 5 from 5